CE Marking vs FDA 510(k): A Side-by-Side Regulatory Comparison for Medtech Founders
Compare CE marking and FDA 510(k) clearance side by side — timelines, costs, clinical evidence requirements, and dual-market entry strategy for medtech founders.
EMA Centralised vs National Authorisation: Which Route Fits Your Drug?
Compare EMA centralised procedure vs national authorisation routes. Understand mandatory scope, timelines, and which pathway fits your drug product.
IND vs NDA: Understanding the FDA’s Two Critical Drug Application Types
Understand the critical differences between IND and NDA submissions in biotech. Learn when each applies, what FDA requires, and how one leads to the other.